205 related articles for article (PubMed ID: 29317340)
21. Role of miR-148a in cutaneous squamous cell carcinoma by repression of MAPK pathway.
Luo Q; Li W; Zhao T; Tian X; Liu Y; Zhang X
Arch Biochem Biophys; 2015 Oct; 583():47-54. PubMed ID: 26253263
[TBL] [Abstract][Full Text] [Related]
22. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous Squamous Cell Carcinoma.
Parekh V; Seykora JT
Clin Lab Med; 2017 Sep; 37(3):503-525. PubMed ID: 28802498
[TBL] [Abstract][Full Text] [Related]
25. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma.
Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK
JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495
[TBL] [Abstract][Full Text] [Related]
26. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma.
Cañueto J; Cardeñoso-Álvarez E; García-Hernández JL; Galindo-Villardón P; Vicente-Galindo P; Vicente-Villardón JL; Alonso-López D; De Las Rivas J; Valero J; Moyano-Sanz E; Fernández-López E; Mao JH; Castellanos-Martín A; Román-Curto C; Pérez-Losada J
Br J Dermatol; 2017 Jul; 177(1):168-178. PubMed ID: 27943259
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
[TBL] [Abstract][Full Text] [Related]
30. Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma.
Sand M; Hessam S; Amur S; Skrygan M; Bromba M; Stockfleth E; Gambichler T; Bechara FG
J Dermatol Sci; 2017 May; 86(2):142-148. PubMed ID: 28187958
[TBL] [Abstract][Full Text] [Related]
31. Ultraviolet radiation-induced differential microRNA expression in the skin of hairless SKH1 mice, a widely used mouse model for dermatology research.
Singh A; Willems E; Singh A; Ong IM; Verma AK
Oncotarget; 2016 Dec; 7(51):84924-84937. PubMed ID: 27793049
[TBL] [Abstract][Full Text] [Related]
32. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
33. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
[TBL] [Abstract][Full Text] [Related]
34. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
35. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
[TBL] [Abstract][Full Text] [Related]
36. High-risk cutaneous squamous cell carcinoma.
Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
[TBL] [Abstract][Full Text] [Related]
37. MAGEA3 Expression in Cutaneous Squamous Cell Carcinoma Is Associated with Advanced Tumor Stage and Poor Prognosis.
Abikhair M; Roudiani N; Mitsui H; Krueger JG; Pavlick A; Lee J; Therrien JP; Meehan SA; Felsen D; Carucci JA
J Invest Dermatol; 2017 Mar; 137(3):775-778. PubMed ID: 27826009
[No Abstract] [Full Text] [Related]
38. Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy.
Palazzo E; Morasso MI; Pincelli C
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059344
[TBL] [Abstract][Full Text] [Related]
39. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
40. CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway.
Chu Z; Zhang X; Li Q; Hu G; Lian CG; Geng S
Int J Oncol; 2019 May; 54(5):1534-1544. PubMed ID: 30816486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
